The Effect of Closed-Loop Versus Conventional Ventilation on Mechanical Power
NCT ID: NCT04827927
Last Updated: 2023-08-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
96 participants
INTERVENTIONAL
2021-07-05
2023-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Closed-loop Versus Conventional Ventilation Mode During Mobilization Period in Critical Care Patients
NCT03176329
Flow-controlled Ventilation (FCV) in Moderate Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19
NCT04894214
Does Automated Closed-Loop Ventilation Reduce the DRiving Pressure Levels in Patients With ARDS
NCT03211494
S4 :Trial Of Fully Closed-Loop Ventilation In ICU.
NCT01781091
Closed Loop Mechanical Ventilation and ECMO
NCT04925518
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Mechanical ventilation can cause ventilator-induced lung injury (VILI). Lung protective ventilation, consisting of a low tidal volume (VT), a low plateau pressure (Pplateau) and a low driving pressure (ΔP) improves survival and shortens duration of ventilation in patients with acute respiratory distress syndrome (ARDS). Lung protective ventilation may also benefit critically ill patients with respiratory failure not caused by ARDS. 'Mechanical Power of ventilation' (MP), the amount of energy per time transferred from the ventilator to the respiratory system, is a summary variable that includes all the components that play a role in VILI. With fully-automated closed-loop ventilation, these components are no longer set by the operator, but under control of the algorithms in the ventilator.
Objective:
To compare MP under INTELLiVENT-adaptive support ventilation (ASV), a fully-automated closed-loop ventilation, with MP under conventional ventilation.
Hypothesis:
INTELLiVENT-ASV compared to conventional ventilation results in a lower MP.
Study design:
National, multicenter, crossover, randomized clinical trial.
Study population:
Invasively ventilated critically ill patients.
Methods:
The ventilator will be randomly switched between INTELLiVENT-ASV for 3 hours and conventional ventilation for 3 hours. The amount of MP is calculated using various equations proposed in the literature.
Study endpoints:
The primary endpoint is the amount of MP with each form of invasive ventilation.
Nature and extent of the burden and risks associated with participation, benefit and group relatedness:
Differences in burden and risks of the two ventilation strategies compared in the current study are not expected. Both modes of ventilation are interchangeably used as part of standard care in the participating centers. No other interventions are performed. Neither the collection of demographic and outcome data, nor the capturing of ventilation characteristics causes harm to patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
INTELLiVENT-ASV
Use of INTELLiVENT-ASV during 3 hours with 30 minutes wash-out time before.
Procedure: INTELLiVENT-ASV
With INTELLiVENT-ASV, the patient's conditions, 'ARDS', 'Chronic Hypercapnia' or 'Traumatic Brain Injury' can be chosen, if applicable. The controllers for minute volume, PEEP and FiO2 are all activated, and the target shifts for etCO2 and SpO2 are adjusted, if necessary.
Conventional Ventilation
Use of conventional ventilation during 3 hours with 30 minutes wash-out time before.
Procedure: Conventional ventilation
With conventional ventilation, the same etCO2 and SpO2 levels are targeted as with INTELLiVENT-ASV, but here the caregiver is fully responsible for choosing the settings.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Procedure: INTELLiVENT-ASV
With INTELLiVENT-ASV, the patient's conditions, 'ARDS', 'Chronic Hypercapnia' or 'Traumatic Brain Injury' can be chosen, if applicable. The controllers for minute volume, PEEP and FiO2 are all activated, and the target shifts for etCO2 and SpO2 are adjusted, if necessary.
Procedure: Conventional ventilation
With conventional ventilation, the same etCO2 and SpO2 levels are targeted as with INTELLiVENT-ASV, but here the caregiver is fully responsible for choosing the settings.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Receiving invasive ventilation through a standard endotracheal (i.e., oral) tube;
* Expected to be ventilated \> 24 hours; and
* Ventilation is applied by a ventilator that can provide INTELLiVENT-ASV and conventional ventilation.
Exclusion Criteria
* No written informed consent;
* Morbidly obese; and
* Any contra-indication for use of INTELLiVENT-ASV
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Reinier de Graaf Groep
OTHER
Dijklander Ziekenhuis
OTHER
University of Zurich
OTHER
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Dr. Marcus J. Schultz
Prof. Dr. Marcus J. Schultz
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marcus J Schultz, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Department of Intensive Care, Amsterdam University Medical Centre - location AMC
Frederique Paulus, PhD
Role: STUDY_DIRECTOR
Department of Intensive Care, Amsterdam University Medical Centre - location AMC
Laura A Buiteman-Kruizinga, RN, BSc
Role: STUDY_DIRECTOR
Department of Intensive Care, Amsterdam University Medical Centre - location AMC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Academic Medical Center
Amsterdam, North Holland, Netherlands
Reinier de Graaf Gasthuis
Delft, , Netherlands
Dijklander Ziekenhuis
Hoorn, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Buiteman-Kruizinga LA, Serpa Neto A, Botta M, List SS, de Boer BH, van Velzen P, Buhler PK, Wendel Garcia PD, Schultz MJ, van der Heiden PLJ, Paulus F; INTELLiPOWER-investigators. Effect of automated versus conventional ventilation on mechanical power of ventilation-A randomized crossover clinical trial. PLoS One. 2024 Jul 30;19(7):e0307155. doi: 10.1371/journal.pone.0307155. eCollection 2024.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
INTELLiPOWER
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.